• 2013

Company Description

A Doylestown, Penn.-based developer of p53-targeted small molecule drugs for the treatment of cancer

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.